![Pietro Scalfaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pietro Scalfaro
No open positions remaining
Profile
Pietro Scalfaro served as a Director on the Supervisory Board of Agendia NV, Director of Diagnoplex SA, Non-Executive Director of Biocartis SA, and Chief Medical Officer of Immunexpress Pty Ltd. He received his undergraduate degree from the University of Lausanne in 1989.
Former positions of Pietro Scalfaro
| Companies | Position | End |
|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Director/Board Member | 31/03/2013 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Chief Tech/Sci/R&D Officer | - |
Diagnoplex SA
 Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Director/Board Member | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Director/Board Member | - |
Training of Pietro Scalfaro
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
- Stock Market
- Insiders
- Pietro Scalfaro
